Millennium Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-275,112
| Closed | -$308K | – | 6214 |
|
|
2025
Q2 | $308K | Buy |
+275,112
| New | +$336K | ﹤0.01% | 5180 |
|
|
2025
Q1 | – | Sell |
-83,468
| Closed | -$510K | – | 6111 |
|
|
2024
Q4 | $510K | Sell |
83,468
-48,874
| -37% | -$581K | ﹤0.01% | 4734 |
|
|
2024
Q3 | $2.19M | Sell |
132,342
-258,871
| -66% | -$2.84M | ﹤0.01% | 3628 |
|
|
2024
Q2 | $2.69M | Sell |
391,213
-303,848
| -44% | -$2.6M | ﹤0.01% | 3273 |
|
|
2024
Q1 | $6.71M | Buy |
695,061
+447,865
| +181% | +$5.19M | ﹤0.01% | 2569 |
|
|
2023
Q4 | $2.05M | Sell |
247,196
-520,867
| -68% | -$3.02M | ﹤0.01% | 3581 |
|
|
2023
Q3 | $6.41M | Sell |
768,063
-216,600
| -22% | -$1.84M | ﹤0.01% | 2464 |
|
|
2023
Q2 | $9.09M | Buy |
984,663
+927,203
| +1,614% | +$10.4M | ﹤0.01% | 2115 |
|
|
2023
Q1 | $790K | Sell |
57,460
-276,725
| -83% | -$5.72M | ﹤0.01% | 4296 |
|
|
2022
Q4 | $5.68M | Buy |
334,185
+42,970
| +15% | +$860K | ﹤0.01% | 2698 |
|
|
2022
Q3 | $6.62M | Sell |
291,215
-298,186
| -51% | -$6.02M | ﹤0.01% | 2619 |
|
|
2022
Q2 | $10.6M | Buy |
589,401
+368,089
| +166% | +$6.56M | 0.01% | 1959 |
|
|
2022
Q1 | $5.92M | Buy |
221,312
+57,558
| +35% | +$1.07M | ﹤0.01% | 2751 |
|
|
2021
Q4 | $4.8M | Buy |
163,754
+148,240
| +956% | +$7.37M | ﹤0.01% | 2946 |
|
|
2021
Q3 | $1.02M | Buy |
+15,514
| New | +$1.19M | ﹤0.01% | 4649 |
|
|
2020
Q4 | – | Sell |
-22,231
| Closed | -$1.56M | – | 5379 |
|
|
2020
Q3 | $1.64K | Sell |
22,231
-24,214
| -52% | -$1.43M | ﹤0.01% | 2750 |
|
|
2020
Q2 | $3.39M | Buy |
46,445
+37,283
| +407% | +$2.27M | ﹤0.01% | 2113 |
|
|
2020
Q1 | $514K | Buy |
+9,162
| New | +$402K | ﹤0.01% | 2863 |
|
|
2019
Q4 | – | Sell |
-253,790
| Closed | -$4.5M | – | 4404 |
|
|
2019
Q3 | $4.5M | Buy |
+253,790
| New | +$5.12M | 0.01% | 1896 |
|
Other funds holding IGMS
Millennium Management's IGMS Position: Q3 2025 in Review
Millennium Management sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 275,112 shares — an estimated $308K sold.
Millennium Management first reported a position in IGMS in Q3 2019 and held it in 19 quarters. The position peaked at $10.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Millennium Management reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Millennium Management sold 275,112 IGM Biosciences shares in Q3 2025, an estimated $308K.
- Millennium Management first reported a position in IGM Biosciences in Q3 2019 and held it in 19 quarters.
- Millennium Management's IGM Biosciences position peaked at $10.6M in Q2 2022.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.